These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7315851)

  • 1. Bromocriptine therapy for "nonfunctioning" pituitary tumors.
    Johnston DG; Hall K; McGregor A; Ross WM; Kendall-Taylor P; Hall R
    Am J Med; 1981 Dec; 71(6):1059-61. PubMed ID: 7315851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Size reduction of a nonfunctioning pituitary adenoma after bromocriptine therapy: case report].
    Takahashi T; Kuwayama A; Katoh T; Ichihara K; Kageyama N; Sasaki F
    No Shinkei Geka; 1984 Jan; 12(1):71-80. PubMed ID: 6717737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid resolution of visual field defects and reduction in macroprolactinoma size with bromocriptine therapy. A case report.
    Kahn SE; Miller JL
    S Afr Med J; 1982 Oct; 62(19):696-9. PubMed ID: 7135127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrence of chromophobe pituitary adenomas after operation and postoperative radiotherapy.
    Salmi J; Grahne B; Valtonen S; Pelkonen R
    Acta Neurol Scand; 1982 Dec; 66(6):681-9. PubMed ID: 7164769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors in the outcome of transsphenoidal surgery for prolactinoma and non-functioning pituitary tumour, including pre-operative bromocriptine therapy.
    Bevan JS; Adams CB; Burke CW; Morton KE; Molyneux AJ; Moore RA; Esiri MM
    Clin Endocrinol (Oxf); 1987 May; 26(5):541-56. PubMed ID: 3665118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Additional antitumoral effects of bromocriptine and radiotherapy in patients with prolactinomas or acromegaly.
    Coculescu M; Alessandrescu D; Stoica T; Simionescu N; Dimitriu V; Oprescu M; Chelmu S; Urba-Navicius V; Isbăşoiu O
    Endocrinologie; 1980; 18(4):277-88. PubMed ID: 7209360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pituitary prolactinomas.
    Nabarro JD
    Clin Endocrinol (Oxf); 1982 Aug; 17(2):129-55. PubMed ID: 6751612
    [No Abstract]   [Full Text] [Related]  

  • 8. Acute psychosis secondary to bromocriptine treatment in a patient with a prolactinoma.
    Cabeza GA; Flores LF; Iñiguez IE; Calarco ZE; Valencia PF
    Rev Invest Clin; 1984; 36(2):147-9. PubMed ID: 6484333
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hypophyseal tumors].
    Bergh T
    Katilolehti; 1980; 85(7-8):245-50. PubMed ID: 6904663
    [No Abstract]   [Full Text] [Related]  

  • 10. Effective bromocriptine therapy for large, calcified prolactinoma--pathogenesis of calcifications.
    Inoue H; Kazuno T; Suzuki M; Ishiyama N; Nakamura T; Takenaka N; Otani M; Shinozaki T; Toya S
    Neurol Med Chir (Tokyo); 1986 Jan; 26(1):26-9. PubMed ID: 2425272
    [No Abstract]   [Full Text] [Related]  

  • 11. Growth and puberty arrest due to prolactinoma.
    Sack J; Friedman E; Tadmor R; Sahar A; Katznelson D
    Acta Paediatr Scand; 1984 Nov; 73(6):863-7. PubMed ID: 6524373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Management of pituitary adenoma secreting prolactin].
    Zárate A; Canales ES; Cano C; Castelo J; Vázquez C; Loyo M
    Gac Med Mex; 1982 Jun; 118(6):215-22. PubMed ID: 7128997
    [No Abstract]   [Full Text] [Related]  

  • 13. Discordant serum alpha-subunit and FSH concentrations in a woman with a pituitary tumour.
    Chapman AJ; MacFarlane IA; Shalet SM; Beardwell CG; Dutton J; Sutton ML
    Clin Endocrinol (Oxf); 1984 Aug; 21(2):123-9. PubMed ID: 6205794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hyperprolactinemia and its treatment (analysis of 107 cases)].
    Wu JZ
    Zhonghua Fu Chan Ke Za Zhi; 1985 Jan; 20(1):34-7, 60. PubMed ID: 4038937
    [No Abstract]   [Full Text] [Related]  

  • 15. [Bromocriptine induced cystic tumour regression in advanced prolactinomas (author's transl)].
    Galvan G; Frick J; Irnberger T
    Dtsch Med Wochenschr; 1981 May; 106(20):637-42. PubMed ID: 7227210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regression of pituitary prolactinoma after treatment with bromocriptine.
    Landolt AM; Wüthrich R; Fellmann H
    Lancet; 1979 May; 1(8125):1082-3. PubMed ID: 86800
    [No Abstract]   [Full Text] [Related]  

  • 17. Reduction of pituitary-tumour size in patients with prolactinomas and acromegaly treated with bromocriptine with or without radiotherapy.
    Wass JA; Moult PJ; Thorner MO; Dacie JE; Charlesworth M; Jones AE; Besser GM
    Lancet; 1979 Jul; 2(8133):66-9. PubMed ID: 87966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and pathological effects of bromocriptine on prolactin-secreting and other pituitary tumors.
    Barrow DL; Tindall GT; Kovacs K; Thorner MO; Horvath E; Hoffman JC
    J Neurosurg; 1984 Jan; 60(1):1-7. PubMed ID: 6689702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Size reduction of extrasellar pituitary tumors during bromocriptine treatment.
    Wollesen F; Andersen T; Karle A
    Ann Intern Med; 1982 Mar; 96(3):281-6. PubMed ID: 7059088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of bromocriptine on pituitary tumour size.
    McGregor AM; Scanlon MF; Hall R; Hall K
    Br Med J; 1979 Sep; 2(6192):700-3. PubMed ID: 509071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.